Sameridine

Sameridine (NIH-10908) acts as a weak partial agonist at the μ-opioid receptor. When administered intrathecally, it induces local anesthesia and analgesia. At low doses, Sameridine minimally affects respiratory function, but higher doses can suppress respiratory response. It is useful for research into analgesic effects.